Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

George Baxter

Nurse Practitioner, Adult Health Seattle, WA Nurse Practitioner

NPI 1649433251 CMS profile 10696973

1536 N 115Th St, Suite 200, Seattle, WA 98133

Open in the dashboard

General payments

$868,105

1,230 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, George Baxter of Seattle, WA is reported in the CMS Open Payments database as having received $868,105 across 1,230 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Adult Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $208,101 256
2024 General $181,655 231
2023 General $172,009 198
2022 General $163,740 265
2021 General $142,600 280

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • George Baxter
  • Nurse Practitioner, Adult Health median
  • Middle half of Nurse Practitioner, Adult Health
  • National median

In program year 2025, general payments to George Baxter were reported at $208,101. Among 12,696 Nurse Practitioner, Adult Health profiles paid that year, the median was $184 and the middle half received between $59 and $580.

Show as a table
Year George Baxter Nurse Practitioner, Adult Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $142,600 $138 $43–$438 $132
2022 $163,740 $165 $54–$494 $149
2023 $172,009 $178 $61–$549 $160
2024 $181,655 $186 $62–$575 $164
2025 $208,101 $184 $59–$580 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Galderma Laboratories, L.P. $766,319 940 payments
  2. AbbVie, Inc. $70,433 190 payments
  3. Allergan Inc. $31,159 96 payments
  4. Merz North America, Inc. $100 1 payment
  5. Revance Therapeutics, Inc. $94 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $696,862 267 payments
  2. Travel and Lodging $99,062 435 payments
  3. Consulting Fee $49,241 37 payments
  4. Food and Beverage $22,940 491 payments
Products named General payments · program years 2021–2025
  1. BOTOX $48,907 161 payments
  2. NATRELLE SALINE-FILLED BREAST IMPLANTS $1,173 1 payment
  3. DYSPORT $570 10 payments
  4. KYBELLA $500 1 payment
  5. DYSPORT $293 6 payments
  6. Xeomin $100 1 payment
  7. DAXXIFY $94 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

1,230 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Adult Health in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record